Rotigotine monotherapy in early parkinson’s disease John C. MorganKapil D. Sethi Clinical Trials Report Pages: 273 - 274
Ropinirole versus levodopa in parkinson’s disease John C. MorganKapil D. Sethi Clinical Trials Report Pages: 274 - 276
Neuroprotection in parkinson’s disease: An elusive goal William C. KollerMaria G. Cersosimo OriginalPaper Pages: 277 - 283
Neuroimaging of Parkinson’s disease and atypical parkinsonism Dennis J. ZgaljardicAndrew Feigin OriginalPaper Pages: 284 - 289
Deep brain stimulation in Parkinson’s disease Kelly E. LyonsRajesh Pahwa OriginalPaper Pages: 290 - 295
Anticonvulsant drug or neuromodulator? The growing case for anticonvulsant uses beyond epilepsy Carl W. Bazil OriginalPaper Pages: 305 - 307
Special populations: The management of seizures in HIV-positive patients Paul MullinGary GreenRohit Bakshi OriginalPaper Pages: 308 - 314
Expanding therapeutic options: Devices and the treatment of refractory epilepsy Steven KarceskiPaul Mullin OriginalPaper Pages: 321 - 328
